Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis

Aim. The aim of the study is to determine the effectiveness of liver transplantation (LT) in the treatment of unresectable hepatocellular carcinoma (HCC) occurred in normal liver.Material and methods. 6 patients with unresectable HCC underwent orthotopic liver transplantation (OLT). The long-term...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. D. Olisov, M. S. Novruzbekov, I. E. Galankina, L. N. Zimina, V. A. Gulyaev, L. V. Donova, M. Sh. Khubutiya
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	hepatocellular carcinoma liver transplantation unresectable hepatocellular carcinoma in non-cirrhotic liver anabolic steroids
Online Access:	https://www.gastro-j.ru/jour/article/view/254
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

The role of calcineurin inhibitors in the progression of hepatocellular carcinoma after liver transplantation
by: O. D. Olisov, et al.
Published: (2022-09-01)

Long-term results of liver transplantation for hepatocellular carcinoma
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01)

Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
by: Kristin E. Goodsell, et al.
Published: (2025-03-01)

FEATURES ARTERIAL ANATOMY OF THE LIVER AND ENDOVASCULAR CHEMOEMBOLIZATION OF THE HEPATIC ARTERY IN THE TREATMENT OF PRIMARY AND METASTATIC LIVER CANCERS
by: V. V. Plechev, et al.
Published: (2017-02-01)

New prognostic model for liver transplantation outcomes in hepatocellular carcinoma
by: S. E. Voskanyan, et al.
Published: (2024-09-01)

Exploring the link between anabolic-androgenic steroids abuse for performance improvement and hepatocellular carcinoma: a literature review
by: Rafael Corrêa Coelho, et al.
Published: (2018-01-01)

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study
by: Yilin Wang, et al.
Published: (2025-04-01)

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level
by: Monika Pazgan-Simon, et al.
Published: (2024-10-01)

Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)
by: I. A. Dzhanyan, et al.
Published: (2023-09-01)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
by: Yoshihiro Inoue, et al.
Published: (2020-09-01)

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
by: Meng Sha, et al.
Published: (2025-02-01)

Retinoic acids and nuclear receptor signaling in liver development: Pathogenic roles in liver diseases
by: Wen Jia, et al.
Published: (2024-03-01)

Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
by: Yutian Chen, et al.
Published: (2025-06-01)

Unresectable ectopic hepatocellular carcinoma in the left sub-diaphragmatic area and retroperitoneum treated with TACE: case report and literature review
by: Chao-Bang Xie, et al.
Published: (2025-12-01)

The comparative analysis of immunohistochemical parameters of primary liver cancer and liver metastases of malignant tumors of solid, trabecular, tubular-glandular structure in puncture trephine biopsy
by: V. A. Tumanskiy, et al.
Published: (2015-12-01)

Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation
by: Hao Xiong, et al.
Published: (2025-03-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

Outcome prediction model for patients with unresectable hepatocellular carcinoma treated with targeted therapy
by: Qiang Ruan, et al.
Published: (2025-08-01)

Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
by: Saisai Zhang, et al.
Published: (2025-02-01)

Diagnostic Accuracy of Sonazoid-Enhanced Ultrasonography for Detection of Liver Metastasis
by: Anas Elgenidy, et al.
Published: (2025-04-01)

Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
by: Mario Uccello, et al.
Published: (2011-01-01)

Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea
by: Sang Yi Moon, et al.
Published: (2025-04-01)

Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial
by: Kugeluke Yalikun, et al.
Published: (2025-05-01)

Isolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
by: A. D. Kaprin, et al.
Published: (2021-12-01)

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis
by: Kun-Ming Chan, et al.
Published: (2025-04-01)

The importance of single-nucleotide gene polymorphisms in the formation of liver cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C
by: I. V. Mannanova, et al.
Published: (2024-06-01)

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
by: Zhang S, et al.
Published: (2025-02-01)

Hepatocellular carcinoma in a sheep
by: Zabid Yener, et al.

Laparoscopic partial liver resection for hepatocellular carcinoma arising from Fontan-associated liver disease: a case report
by: Miku Iwata, et al.
Published: (2021-05-01)

Morphological and Functional Changes in Hepatic System Precipitate Liver Disease in Elderly: Addressing Knowledge Gaps and Treatment Challenges
by: Fatrian Dwicahya, et al.
Published: (2024-12-01)

Mechanisms of HRAS regulation of liver hepatocellular carcinoma for prognosis prediction
by: Xingbao Fang, et al.
Published: (2025-04-01)

Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma
by: Qingqing Pang, et al.
Published: (2025-07-01)

Liver Transplantation for Liver-Originated Malignancy: A Single Center Experience
by: Ramazan Kozan, et al.
Published: (2024-07-01)

The predictive value of PIV, PLR, LMR, NPR, and NLR for the prognosis of transarterial chemoembolization in patients with hepatocellular carcinoma combined with liver cirrhosis
by: Yanan Wei, et al.
Published: (2025-04-01)

Unmasking Hepatocellular Carcinoma in a Non-Cirrhotic Liver: A Case Report of an Advanced Tumor in the Absence of Traditional Risk Factors
by: Nora Abdul-Aziz, et al.
Published: (2025-06-01)

Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
by: Sniedze Laivacuma, et al.
Published: (2025-04-01)

Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors
by: Mohammad Saeid Rezaee-Zavareh, et al.
Published: (2025-07-01)

Role of cytokines in hepatocellular carcinoma
by: T. Aghayev, et al.
Published: (2022-11-01)